Literature DB >> 24507827

Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.

Zhixiang Xu1, Wei Yin1, Leonardo K Martinelli2, Joanna Evans3, Jinglei Chen1, Yang Yu1, Daniel J Wilson2, Valerie Mizrahi3, Chunhua Qiao4, Courtney C Aldrich5.   

Abstract

The biosynthesis of pantothenate, the core of coenzyme A (CoA), has been considered an attractive target for the development of antimicrobial agents since this pathway is essential in prokaryotes, but absent in mammals. Pantothenate synthetase, encoded by the gene panC, catalyzes the final condensation of pantoic acid with β-alanine to afford pantothenate via an intermediate pantoyl adenylate. We describe the synthesis and biochemical characterization of five PanC inhibitors that mimic the intermediate pantoyl adenylate. These inhibitors are competitive inhibitors with respect to pantoic acid and possess submicromolar to micromolar inhibition constants. The observed SAR is rationalized through molecular docking studies based on the reported co-crystal structure of 1a with PanC. Finally, whole cell activity is assessed against wild-type Mtb as well as a PanC knockdown strain where PanC is depleted to less than 5% of wild-type levels.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenylation; Bisubstrate inhibitor; Coenzyme A; Pantothenate synthetase; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24507827      PMCID: PMC4667779          DOI: 10.1016/j.bmc.2014.01.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  35 in total

1.  Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

Authors:  Vasan K Sambandamurthy; Steven C Derrick; Kripa V Jalapathy; Bing Chen; Robert G Russell; Sheldon L Morris; William R Jacobs
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase.

Authors:  R Zheng; J S Blanchard
Journal:  Biochemistry       Date:  2001-10-30       Impact factor: 3.162

3.  Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.

Authors:  Hernani Leonardo Silvestre; Thomas L Blundell; Chris Abell; Alessio Ciulli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-19       Impact factor: 11.205

4.  Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.

Authors:  Alvin W Hung; H Leonardo Silvestre; Shijun Wen; Alessio Ciulli; Tom L Blundell; Chris Abell
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.

Authors:  E Lucile White; Kristen Southworth; Larry Ross; Sara Cooley; Rachel B Gill; Melinda Ingrum Sosa; Anna Manouvakhova; Lynn Rasmussen; Celia Goulding; David Eisenberg; Thomas M Fletcher
Journal:  J Biomol Screen       Date:  2006-12-14

6.  Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.

Authors:  Benjamin P Duckworth; Todd W Geders; Divya Tiwari; Helena I Boshoff; Paul A Sibbald; Clifton E Barry; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  Chem Biol       Date:  2011-11-23

7.  The design and synthesis of inhibitors of pantothenate synthetase.

Authors:  Kellie L Tuck; S Adrian Saldanha; Louise M Birch; Alison G Smith; Chris Abell
Journal:  Org Biomol Chem       Date:  2006-08-30       Impact factor: 3.876

8.  Modular synthesis of pantetheine and phosphopantetheine.

Authors:  Alexander L Mandel; James J La Clair; Michael D Burkart
Journal:  Org Lett       Date:  2004-12-23       Impact factor: 6.005

9.  A spectrophotometric method to measure enzymatic activity in reactions that generate inorganic pyrophosphate.

Authors:  R H Upson; R P Haugland; M N Malekzadeh; R P Haugland
Journal:  Anal Biochem       Date:  1996-12-01       Impact factor: 3.365

Review 10.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

View more
  10 in total

Review 1.  Future target-based drug discovery for tuberculosis?

Authors:  Bavesh Davandra Kana; Petros C Karakousis; Tanya Parish; Thomas Dick
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

2.  Improved Synthesis of Biotinol-5'-AMP: Implications for Antibacterial Discovery.

Authors:  William Tieu; Steven W Polyak; Ashleigh S Paparella; Min Y Yap; Tatiana P Soares da Costa; Belinda Ng; Geqing Wang; Richard Lumb; Jan M Bell; John D Turnidge; Matthew C J Wilce; Grant W Booker; Andrew D Abell
Journal:  ACS Med Chem Lett       Date:  2014-12-11       Impact factor: 4.345

3.  Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.

Authors:  Tony D Davis; Poornima Mohandas; Maria I Chiriac; Glennon V Bythrow; Luis E N Quadri; Derek S Tan
Journal:  Bioorg Med Chem Lett       Date:  2016-09-16       Impact factor: 2.823

4.  Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Authors:  Elaine Ballinger; John Mosior; Travis Hartman; Kristin Burns-Huang; Ben Gold; Roxanne Morris; Laurent Goullieux; Isabelle Blanc; Julien Vaubourgeix; Sophie Lagrange; Laurent Fraisse; Stéphanie Sans; Cedric Couturier; Eric Bacqué; Kyu Rhee; Sarah M Scarry; Jeffrey Aubé; Guangbin Yang; Ouathek Ouerfelli; Dirk Schnappinger; Thomas R Ioerger; Curtis A Engelhart; Jennifer A McConnell; Kathrine McAulay; Allison Fay; Christine Roubert; James Sacchettini; Carl Nathan
Journal:  Science       Date:  2019-02-01       Impact factor: 47.728

5.  Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity.

Authors:  Joanna C Evans; Dinakaran Murugesan; John M Post; Vitor Mendes; Zhe Wang; Navid Nahiyaan; Sasha L Lynch; Stephen Thompson; Simon R Green; Peter C Ray; Jeannine Hess; Christina Spry; Anthony G Coyne; Chris Abell; Helena I M Boshoff; Paul G Wyatt; Kyu Y Rhee; Tom L Blundell; Clifton E Barry; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2021-05-03       Impact factor: 5.084

Review 6.  Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors:  Michaelyn C Lux; Lisa C Standke; Derek S Tan
Journal:  J Antibiot (Tokyo)       Date:  2019-04-15       Impact factor: 2.649

Review 7.  Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents.

Authors:  Hailey S Butman; Timothy J Kotzé; Cynthia S Dowd; Erick Strauss
Journal:  Front Cell Infect Microbiol       Date:  2020-12-15       Impact factor: 5.293

Review 8.  Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis - a medicinal chemist perspective.

Authors:  Amaroju Suresh; Singireddi Srinivasarao; Yogesh Mahadu Khetmalis; Shashidhar Nizalapur; Murugesan Sankaranarayanan; Kondapalli Venkata Gowri Chandra Sekhar
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 4.036

Review 9.  The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis.

Authors:  Joanna C Evans; Valerie Mizrahi
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

10.  Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis.

Authors:  Joanna C Evans; Carolina Trujillo; Zhe Wang; Hyungjin Eoh; Sabine Ehrt; Dirk Schnappinger; Helena I M Boshoff; Kyu Y Rhee; Clifton E Barry; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2016-10-05       Impact factor: 5.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.